(CNXT) ChiNext - NYSE
ETF Category: Greater China Region | Exchange: NYSE (USA) | Market Cap: 149m USD | Total Return: 111.4% in 12m
Avg Turnover: 8.05M
Warnings
No concerns identified
Tailwinds
Avwap Ph Week
The VanEck ChiNext ETF (CNXT) tracks the performance of the 100 largest and most liquid China A-shares listed on the Shenzhen Stock Exchange’s ChiNext Market. Launched in 2014, the fund maintains a policy of investing at least 80% of its assets in the constituent securities of its underlying free-float adjusted index.
The ChiNext Market functions as a growth-oriented board, often compared to the NASDAQ, primarily featuring companies in the technology, healthcare, and clean energy sectors. These firms typically utilize a high-growth business model focused on domestic innovation and research and development within the Chinese economy. Investors can use ValueRay to further analyze the specific valuation metrics of these underlying holdings. The fund provides direct exposure to mainland-listed equities that were historically restricted to foreign investors.
- China monetary stimulus and interest rate cuts drive equity valuations
- Growth in Shenzhen technology and healthcare sectors fuels revenue expansion
- Geopolitical tensions and trade restrictions impact semiconductor export potential
- Regulatory shifts in China A-share markets influence foreign capital inflows
As of June 16, 2026, the stock is trading at USD 57.74 with a total of 74,614 shares traded.
Over the past week, the price has changed by +7.08%,
over one month by +3.72%,
over three months by +23.83% and
over the past year by +111.37%.
ChiNext has no consensus analysts rating.